Evidence map›Paper›PMID 30733274›Full record

ArticleHaematologica2019

Serendipity: decitabine monotherapy induced complete molecular response in a 77-year-old patient with acute promyelocytic leukemia.

Ramzi Abboud, Se Young Han, Eric J Duncavage, Amanda F Cashen, Cara Lunn Shirai, John S Welch, John F DiPersio, Camille N Abboud

Abstract readCase ReportsLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Haematologica, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ramzi AbboudBMT and Leukemia Program, Department of Medicine, Washington University School of Medicine, Saint Louis, MO.
Se Young HanHematology, Oncology, and Transplantation Division, Department of Medicine, University of Minneapolis, MN, USA.
Eric J DuncavageBMT and Leukemia Program, Department of Medicine, Washington University School of Medicine, Saint Louis, MO.
Amanda F CashenBMT and Leukemia Program, Department of Medicine, Washington University School of Medicine, Saint Louis, MO.
Cara Lunn ShiraiBMT and Leukemia Program, Department of Medicine, Washington University School of Medicine, Saint Louis, MO.
John S WelchBMT and Leukemia Program, Department of Medicine, Washington University School of Medicine, Saint Louis, MO.
John F DiPersioBMT and Leukemia Program, Department of Medicine, Washington University School of Medicine, Saint Louis, MO.
Camille N AbboudBMT and Leukemia Program, Department of Medicine, Washington University School of Medicine, Saint Louis, MO cabboud@wustl.edu.

Funding

Targeting the Bone Marrow Microenvironment In Acute Lymphocytic LeukemiaP50CA171963 · NCI · WASHINGTON UNIVERSITY · PI Daniel C Link · 2013 to 2026
$31.6M
RETINOIDS IN HEMATOPOIESISR01HL128447 · NHLBI · WASHINGTON UNIVERSITY · PI WELCH, JOHN S · 2016 to 2020
$1.9M
Washington University Cancer Genomics and Outcomes Research STRENGTH ProgramR25CA190190 · NCI · WASHINGTON UNIVERSITY · PI GOVINDAN, RAMASWAMY · 2015 to 2019
$1.0M
NCI NIH HHS P50 CA171963NCI NIH HHS R25 CA190190NHLBI NIH HHS R01 HL128447
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AgedAntigens, CDDecitabineFemaleHumansLeukemia, Promyelocytic, AcuteOncogene Proteins, FusionAntigens, CDDecitabineOncogene Proteins, Fusionpromyelocytic leukemia-retinoic acid receptor alpha fusion oncoprotein

Identifiers

PMID30733274
PMCPMC6442953

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.